Biostage Inc. said Nasdaq will complete the delisting process for its common stock, after it failed to regain compliance with the rules.
The biotech company receive the notice of suspension in October. Concurrently, it started trading on the OTCQB marketplace under the symbol BSTG.
Biostage said the Nasdaq delisting will not affect its OTCQB marketplace listing.